Sign in
Response to high dose escalation therapy with sebelipase alfa in a patient with severe infantile lysosomal acid lipase deficiency (ILALD) and further insight into this disease
Journal article   Peer reviewed

Response to high dose escalation therapy with sebelipase alfa in a patient with severe infantile lysosomal acid lipase deficiency (ILALD) and further insight into this disease

Moeenaldeen AlSayed, Rozeena Huma and Wijdan Ahmad
Molecular genetics and metabolism, Vol.120(1-2), p.S21
01/2017

Metrics

1 Record Views

Details